Arcus Biosciences, Inc. (RCUS)

23.06 -0.06 (-0.26%) USD  |  NYSE  |  Dec 26, 12:39
More

Arcus Biosciences Proceeds from Stock Option Exercised (Quarterly)

Proceeds from Stock Option Exercised (Quarterly) Chart

View Proceeds from Stock Option Exercised (Quarterly) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Quarterly) Benchmarks

View Proceeds from Stock Option Exercised (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Actinium Pharmaceuticals, Inc. Upgrade
Apyx Medical Corp. Upgrade
Merck & Co., Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade